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Translocator Protein in Brain Tissue and Neurodegeneration
Abstract
Neurodegenerative disorders, such as Alzheimer's Disease, effect over 50 million Americans a year, and
despite the high prevalence, the pathogenesis of these diseases remains unclear. However, researchers
have noticed a dramatic up-regulation of a protein called translocator protein (TSPO) under
neurodegenerative and neuro-inflammatory conditions. While TSPO expression is prevalent in the brain, it
is still unclear as to what exact types of cells TSPO is expressed in, and what mechanisms result in
increased expression. Regulating the expression or function of TSPO is believed to have an impact on
neurodegenerative processes, but definitive evidence of this is also limited. To advance our
understanding we will examine what cells TSPO is expressed in, and reveal what effects TSPO agonists
and antagonists will have on brain activity patterns using electroencephalography. Some research has
found that certain TSPO ligands have potential to be therapeutic agents for neurodegeneration, neuroinflammation and neurotrauma. Therefore, localization of TSPO in brain tissue and investigation of the
mechanism by which it becomes activated, may allow for the development of novel treatments for
neurodegenerative issues such as Alzheimer's.
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ABSTRACT
Neurodegenerative disorders, such as Alzheimer's Disease, effect over 50 million
Americans a year, and despite the high prevalence, the pathogenesis of these diseases remains
unclear. However, researchers have noticed a dramatic up-regulation of a protein called
translocator protein (TSPO) under neurodegenerative and neuro-inflammatory conditions. While
TSPO expression is prevalent in the brain, it is still unclear as to what exact types of cells TSPO
is expressed in, and what mechanisms result in increased expression. Regulating the expression or
function of TSPO is believed to have an impact on neurodegenerative processes, but definitive
evidence of this is also limited. To advance our understanding we will examine what cells TSPO
is expressed in, and reveal what effects TSPO agonists and antagonists will have on brain activity
patterns using electroencephalography. Some research has found that certain TSPO ligands have
potential to be therapeutic agents for neurodegeneration, neuro-inflammation and neurotrauma.
Therefore, localization of TSPO in brain tissue and investigation of the mechanism by which it
becomes activated, may allow for the development of novel treatments for neurodegenerative
issues such as Alzheimer's.
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